- The CME Group announced that it will launch XRP futures trading in May, pending a regulatory review.
- XRP futures will add to the company’s suite of crypto products, which include its recently launched Solana futures.
- XRP held still at $2.21 following the announcement.
XRP trades around $2.21 on Thursday following the Chicago Mercantile Exchange (CME) Group’s announcement that it is planning to launch a futures product for the remittance-based token on May 19. This will add to the exchange’s list of crypto derivatives, including Bitcoin, Ethereum and Solana futures.
CME to launch XRP futures weeks after its Solana product went live
Derivatives exchange CME Group intends to list XRP futures as part of its suite of crypto products. The product is set to go live on May 19, pending a review by regulators.
The XRP futures will allow traders to speculate on the price of XRP without owning the underlying cryptocurrency. The contracts will be cash-settled, meaning any gains or losses will be settled in US Dollars (USD) instead of delivering actual XRP tokens when the contract expires.
The pricing of these contracts will be based on the CME CF XRP-Dollar Reference Rate, which is a benchmark price representing the US Dollar value of XRP. The rate will be calculated once a day at 16:00 GMT using data from major crypto exchanges, ensuring a consistent and transparent settlement price.
Investors in the CME Group’s XRP futures will be eligible to trade micro-sized contracts containing up to 2,500 XRP and larger-sized contracts with up to 50,000 XRP.
“Interest in XRP and its underlying ledger (XRPL) has steadily increased as institutional and retail adoption for the network grows, and we are pleased to launch these new futures contracts to provide a capital-efficient toolset to support clients’ investment and hedging strategies,” said Giovanni Vicioso, Global Head of Cryptocurrency Products at CME Group, in a press release.
The XRP futures adds to the exchange’s existing product suite, which includes Bitcoin, Ethereum and Solana futures.
Crypto community members are anticipating that the CME’s XRP futures launch may strengthen the chances of regulatory approval for several spot XRP exchange-traded fund (ETF) applications. The Securities and Exchange Commission (SEC) cited the CME’s Bitcoin and Ethereum futures price feeds as key references during the approval process of ETF filings for both cryptocurrencies.
XRP held steady at $2.21 at publication time, recovering from an earlier decline of $2.13. The remittance-based token is up 6% in the weekly timeframe.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Leave feedback about this